NEW YORK (dpa-AFX Broker) - U.S. bank JPMorgan left its rating on Siemens Healthineers at "Overweight" with a price target of 62.10 euros. Price performance in the medical technology sector has been terrible in 2022, analyst David Adlington wrote in a research note issued Tuesday. He added that inflation was nightmare for the sector and was likely to be the biggest headwind in 2023 as well. However, he said things could conceivably improve in the second half of the year. His top recommendation in the sector is Siemens Healthineers: the stock offers revaluation potential due to bulging order books./tih/la

Publication of the original study: 02.01.2023 / 19:21 / GMT

First disclosure of the original study: 03.01.2023 / 00:15 / GMT

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------